PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License
'We believe that this delivery sets a precedent in terms of the innovative terms agreed-to with Merhavim – terms that allows researchers to explore new and complex mental health indications with less financial risk while allowing PharmAla to develop important intellectual property in a cost-effective manner,' said Nick Kadysh, CEO of PharmAla Biotech. 'However it also continues to show PharmAla's ability to work rapidly on behalf of our clients, with just 6 months between execution and delivery of the shipment – even with complexity in not only cross-border trade and tariff pressure, but also a significant conflict in the region.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
2 days ago
- Toronto Star
Questerre reports second quarter 2025 results
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Aug. 08, 2025 (GLOBE NEWSWIRE) — Questerre Energy Corporation ('Questerre' or the 'Company') (TSX,OSE:QEC) reported today on its financial and operating results for the second quarter ended June 30, 2025.
Toronto Star
2 days ago
- Toronto Star
Q-Gold Provides Corporate Update
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR) ('Q-Gold' or the 'Company') is pleased to provide the following corporate update on its recent and upcoming activities, including as they relate to the later stage mineral exploration project located in south-central Oregon (the 'Quartz Mountain Project') that the Company intends to acquire from Alamos Gold Inc. ('Alamos') pursuant to a share exchange agreement dated March 31, 2025 (the 'Acquisition'). For more information about the Acquisition and the Quartz Mountain Project, please see the Company's press release dated April 3, 2025, a copy of which is available under the Company's SEDAR+ profile at The Company is pleased to announce that, in addition to being appointed as the Company's chief executive officer and president (see the Company's press release dated July 17, 2025), Peter Tagliamonte has joined the Company's board of directors, effective immediately.
Toronto Star
2 days ago
- Toronto Star
Intermap Announces Date for Second Quarter Earnings
DENVER, Aug. 08, 2025 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) ('Intermap' or the 'Company'), a global leader in 3D geospatial products and intelligence solutions, today announced that it plans to release second quarter 2025 financial results after market close on Thursday, August 14, 2025. Intermap's CEO Patrick A. Blott and CFO Jennifer Bakken will host a live webinar on Thursday, August 14, 2025 at 5:00 pm ET to review the results, provide Company updates and answer investor questions following the presentation.
